Clinical and analytical validation for HRD status using targeted panel sequencing. H Bao, R Liu, H Tang, X Wu, X Chen, Y Wu, X Wu, Y Shao Journal of Clinical Oncology 42 (16_suppl), e17501-e17501, 2024 | | 2024 |
Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study DZ Guo, A Huang, YC Wang, S Zhou, H Wang, XL Xing, SY Zhang, ... Clinical and Translational Medicine 14 (5), e1652, 2024 | | 2024 |
Compositions and methods for library construction and sequence analysis AG Jeffrey, A Gore, R Liu US Patent 11,965,157, 2024 | 1 | 2024 |
P718: Analytical validation of a comprehensive targeted DNA sequencing panel for hematologic malignancies R Yu, H Bao, R Liu, H Tang, Y Wu, L Zhu, K Liu, S Liu, X Wu, Y Shao Genetics in Medicine Open 2, 2024 | | 2024 |
Circulating cell-free DNA-based early detection K Zhang, R Fu, R Liu, Z Su Trends in Cancer, 2023 | 3 | 2023 |
Cross-platform comparisons for targeted bisulfite sequencing of MGISEQ-2000 and NovaSeq6000 J Sun, M Su, J Ma, M Xu, C Ma, W Li, R Liu, Q He, Z Su Clinical Epigenetics 15 (1), 130, 2023 | 1 | 2023 |
Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation Z Wang, K Xie, G Zhu, C Ma, C Cheng, Y Li, X Xiao, C Li, J Tang, H Wang, ... Respiratory Research 24 (1), 163, 2023 | 6 | 2023 |
Early detection of molecular residual disease and risk stratification for stage I to III colorectal cancer via circulating tumor DNA methylation S Mo, L Ye, D Wang, L Han, S Zhou, H Wang, W Dai, Y Wang, W Luo, ... JAMA oncology 9 (6), 770-778, 2023 | 26 | 2023 |
Multidimensional cell-free DNA fragmentomic assay for detection of early-stage lung cancer S Wang, F Meng, M Li, H Bao, X Chen, M Zhu, R Liu, X Xu, S Yang, X Wu, ... American Journal of Respiratory and Critical Care Medicine 207 (9), 1203-1213, 2023 | 22 | 2023 |
Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma S Hong, B Lin, M Xu, Q Zhang, Z Huo, M Su, C Ma, J Liang, S Yu, Q He, ... EBioMedicine 90, 2023 | 4 | 2023 |
Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma R Liu, Z Cao, M Wu, X Li, P Fan, Z Liu BMC Medical Genomics 16 (1), 60, 2023 | | 2023 |
A novel prognostic model for papillary thyroid cancer based on epithelial–mesenchymal transition‐related genes R Liu, Z Cao, M Pan, M Wu, X Li, H Yuan, Z Liu Cancer Medicine 11 (23), 4703-4720, 2022 | 4 | 2022 |
Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA H Wu, S Guo, X Liu, Y Li, Z Su, Q He, X Liu, Z Zhang, L Yu, X Shi, S Gao, ... BMC medicine 20 (1), 458, 2022 | 14 | 2022 |
Nomograms Based on Serum N-glycome for Diagnosis of Papillary Thyroid Microcarcinoma and Prediction of Lymph Node Metastasis Z Zhang, Z Cao, R Liu, Z Li, J Wu, X Liu, M Wu, X Xu, Z Liu Current Oncology 29 (9), 6018-6034, 2022 | 3 | 2022 |
Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomics X Zhang, Z Wang, W Tang, X Wang, R Liu, H Bao, X Chen, Y Wei, S Wu, ... Hepatology 76 (2), 317-329, 2022 | 56 | 2022 |
Cross-platform comparisons for DNA methylation sequencing M Su, J Sun, J Ma, J Xia, C Ma, W Li, Z Su, Q He, R Liu Cancer Research 82 (12_Supplement), 6201-6201, 2022 | | 2022 |
Plasma cell-free DNA fragmentation patterns combined with tumor mutation detection in diagnosis of lung cancer Z Wang, M Xu, H Chen, K Xie, M Su, Q He, Z Su, R Liu, W Li Cancer Research 82 (12_Supplement), 6202-6202, 2022 | | 2022 |
Non-invasive early detection of pancreatic ductal adenocarcinoma using methylation signatures in circulating tumor DNA AJ Gore, J Dang, A Fung, B Xie, R Liu Cancer Research 82 (12_Supplement), 1421-1421, 2022 | | 2022 |
Serum Linkage-Specific Sialylation Changes Are Potential Biomarkers for Monitoring and Predicting the Recurrence of Papillary Thyroid Cancer Following Thyroidectomy Z Cao, Z Zhang, R Liu, M Wu, Z Li, X Xu, Z Liu Frontiers in endocrinology 13, 858325, 2022 | 2 | 2022 |
Development of PCR assays to detect signature circulating tumor DNA methylation markers and KRas mutations for pancreatic ductal adenocarcinoma (PDAC). S Guo, M Su, X Shi, S Gao, H Wang, Y Pan, C Gong, Q He, R Liu, G Jin Journal of Clinical Oncology 40 (4_suppl), 524-524, 2022 | 1 | 2022 |